| pubmed-article:10175551 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10175551 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:10175551 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:10175551 | lifeskim:mentions | umls-concept:C0021461 | lld:lifeskim |
| pubmed-article:10175551 | lifeskim:mentions | umls-concept:C1881212 | lld:lifeskim |
| pubmed-article:10175551 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:10175551 | pubmed:dateCreated | 1998-2-13 | lld:pubmed |
| pubmed-article:10175551 | pubmed:abstractText | Managed care plans evaluate therapeutic alternatives to identify the most cost-effective medications for asthma. Three hundred one patients with asthma were randomized to receive the beta-agonist pirbuterol from either a manually operated metered dose inhaler (MDI) or a breath-actuated inhaler (BAI). Cost effectiveness was evaluated by the cost of the beta-agonist medication used and patient-reported outcomes. No significant differences between the two groups appeared in baseline or follow-up outcomes, which were assessed by self-reported health status and spirometry. However, patients receiving pirbuterol from BAIs used 23% less than those patients who received the drug from MDIs. | lld:pubmed |
| pubmed-article:10175551 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10175551 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10175551 | pubmed:citationSubset | H | lld:pubmed |
| pubmed-article:10175551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10175551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10175551 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10175551 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10175551 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:10175551 | pubmed:issn | 1096-5645 | lld:pubmed |
| pubmed-article:10175551 | pubmed:author | pubmed-author:WyattRR | lld:pubmed |
| pubmed-article:10175551 | pubmed:author | pubmed-author:KellowayJ SJS | lld:pubmed |
| pubmed-article:10175551 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10175551 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:10175551 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10175551 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10175551 | pubmed:pagination | 99-107 | lld:pubmed |
| pubmed-article:10175551 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:meshHeading | pubmed-meshheading:10175551... | lld:pubmed |
| pubmed-article:10175551 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:10175551 | pubmed:articleTitle | A cost-effectiveness analysis of breath-actuated metered-dose inhalers. | lld:pubmed |
| pubmed-article:10175551 | pubmed:affiliation | Asthma and Allergy Research Center, Institute for Research and Education, Park Nicollet Clinic, Minneapolis, MN 55416, USA. | lld:pubmed |
| pubmed-article:10175551 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10175551 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10175551 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10175551 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10175551 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10175551 | lld:pubmed |
